BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12694882)

  • 1. Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: the influence of charge density and size of the proteins molecules.
    Yamasaki Y; Hisazumi J; Yamaoka K; Takakura Y
    Eur J Pharm Sci; 2003 Apr; 18(5):305-12. PubMed ID: 12694882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors.
    Yamasaki Y; Sumimoto K; Nishikawa M; Yamashita F; Yamaoka K; Hashida M; Takakura Y
    J Pharmacol Exp Ther; 2002 May; 301(2):467-77. PubMed ID: 11961045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA.
    Swart PJ; Beljaars E; Smit C; Pasma A; Schuitemaker H; Meijer DK
    J Drug Target; 1996; 4(2):109-16. PubMed ID: 8894971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of FH by two types of scavenger-like receptors in rat liver parenchymal cells in primary culture.
    Nakamura T; Yuasa H; Inoue K; Hayashi Y; Watanab J
    Biol Pharm Bull; 2002 Mar; 25(3):356-60. PubMed ID: 11913533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver: one or two receptors?
    Dresel HA; Friedrich E; Via DP; Sinn H; Ziegler R; Schettler G
    EMBO J; 1987 Feb; 6(2):319-26. PubMed ID: 3582361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells.
    Smedsrød B; Melkko J; Araki N; Sano H; Horiuchi S
    Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):567-73. PubMed ID: 9065778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells.
    Bijsterbosch MK; Manoharan M; Rump ET; De Vrueh RL; van Veghel R; Tivel KL; Biessen EA; Bennett CF; Cook PD; van Berkel TJ
    Nucleic Acids Res; 1997 Aug; 25(16):3290-6. PubMed ID: 9241243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties.
    Nishikawa M; Miyazaki C; Yamashita F; Takakura Y; Hashida M
    Am J Physiol; 1995 May; 268(5 Pt 1):G849-56. PubMed ID: 7762669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A).
    Nakajou K; Horiuchi S; Sakai M; Haraguchi N; Tanaka M; Takeya M; Otagiri M
    Diabetologia; 2005 Feb; 48(2):317-27. PubMed ID: 15654600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scavenger receptor-mediated recognition of maleylated albumin and its relation to subsequent endocytic degradation.
    Takata K; Horiuchi S; Morino Y
    Biochim Biophys Acta; 1989 Sep; 984(3):273-80. PubMed ID: 2775777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of in vivo fate of albumin derivatives utilizing combined chemical modification.
    Fujita T; Nishikawa M; Ohtsubo Y; Ohno J; Takakura Y; Sezaki H; Hashida M
    J Drug Target; 1994; 2(2):157-65. PubMed ID: 8069594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors.
    Biessen EA; Vietsch H; Kuiper J; Bijsterbosch MK; Berkel TJ
    Mol Pharmacol; 1998 Feb; 53(2):262-9. PubMed ID: 9463484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.
    Opanasopit P; Nishikawa M; Yamashita F; Takakura Y; Hashida M
    J Drug Target; 2001; 9(5):341-51. PubMed ID: 11770704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum is a rich source of ligands for the scavenger receptor of hepatic sinusoidal endothelial cells.
    Hansen B; Melkko J; Smedsrød B
    Mol Cell Biochem; 2002 Jan; 229(1-2):63-72. PubMed ID: 11936848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor-mediated process in rats.
    Stehle G; Wunder A; Sinn H; Schrenk HH; Friedrich EA; Dempfle CE; Maier-Borst W; Heene DL
    J Surg Res; 1995 Feb; 58(2):197-204. PubMed ID: 7861773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
    Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
    Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of acetyl-LDL and Mal-BSA with scavenger receptor sites of rat liver.
    Dresel HA; Otnad E; Friedrich E; Sinn H; Schettler G; Ziegler R
    Agents Actions Suppl; 1988; 26():159-63. PubMed ID: 3064569
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A.
    Matsumoto K; Sano H; Nagai R; Suzuki H; Kodama T; Yoshida M; Ueda S; Smedsrød B; Horiuchi S
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):233-40. PubMed ID: 11062078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of oxidized and chemically modified low density lipoproteins in rainbow trout--clearance via scavenger receptors.
    Frøystad MK; Volden V; Berg T; Gjøen T
    Dev Comp Immunol; 2002 Oct; 26(8):723-33. PubMed ID: 12206836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic properties of LMW-heparin-tyramine fractions with high or low affinity to antithrombin III in the rat.
    Stehle G; Wunder A; Sinn H; Schrenk HH; Harenberg J; Malsch R; Maier-Borst W; Heene DL
    Semin Thromb Hemost; 1997; 23(1):31-7. PubMed ID: 9156408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.